StockData

Research Alliance Corp III (RACC) stock

RACCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$10.12+0.00 (0.00%)

Close on Nov 17, 2026Market cap $92.08MP/E –Yield –

Research Alliance Corp III operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

No operating cash flow figures for Research Alliance Corp III

Research Alliance Corp III has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Research Alliance Corp III figures

See a number that looks wrong?